Concepedia

Publication | Open Access

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

DOIFull Paper Access

142

Citations

27

References

2022

Year

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt, Andrzej Budaj, Rosa Coppolecchia, John W. Eikelboom, Stefan James, W. Schuyler Jones, Béla Merkely, Lars Keller,
Circulation

Abstract

gov; Unique identifier: NCT04304534; URL: https://www.clinicaltrialsregister.eu/ctr-search/search; Unique identifier: 2019-003244-79.

References

YearCitations

Page 1